| name | KSB-D02-K0077 |
| description | AI-Personalized ADR Risk Assessment: Understanding of AI approaches for personalized ADR risk assessment including patient-specific risk ... |
| version | 1.0.0 |
| domain | D02 |
| domain_name | Clinical Aspects of ADRs |
| type | Knowledge |
| proficiency_level | L4 |
| bloom_level | analyze |
| triggers | ["explain ai-personalized adr risk assessment","what is ai-personalized adr risk assessment","analyze ai-personalized adr risk assessment"] |
| epa_mapping | EPA-01, EPA-02, EPA-05 |
| cpa_mapping | CPA-01, CPA-02 |
| regulatory_refs | |
KSB-D02-K0077: AI-Personalized ADR Risk Assessment
Overview
Domain: D02 - Clinical Aspects of ADRs
Type: Knowledge
Proficiency Level: L4 (Proficient - Independent practice)
Bloom Level: Analyze
Description
Understanding of AI approaches for personalized ADR risk assessment including patient-specific risk models, individual response prediction, personalized monitoring protocols, and AI-driven shared decision-making support.
Context
- Major Section: AI-Enhanced ADR Analysis
- Section: Patient-Specific AI
EPA Mapping
- EPA-01:3001-3003
- EPA-02:3004-3005
- EPA-05:3011-3012
CPA Pathway
Regulatory References
Instructions
When this skill is activated, Claude should:
- Demonstrate L4 proficiency in ai-personalized adr risk assessment
- Apply analyze level cognitive skills to analyze the topic
- Reference relevant regulatory guidance (general PV standards)
- Connect to related EPAs: EPA-01, EPA-02, EPA-05
Key Competencies
- Understanding of AI approaches for personalized ADR risk assessment including patient-specific risk models, individual response prediction, personalized monitoring protocols, and AI-driven shared decision-making support.
Assessment Criteria
- Can analyze core concepts independently
- Demonstrates understanding of regulatory context
- Applies knowledge appropriately to PV scenarios
Related Skills
- Other D02 skills in Patient-Specific AI
- Cross-domain integrations per DAG architecture
Generated from PV KSB Framework v1.0 | 2025-12-31